Study Shows Lipid Nanoparticles Can Deliver Gene Therapy to Spinal Cord Injuries via Disrupted Blood Barrier
Researchers demonstrated that lipid nanoparticles carrying mRNA can cross the damaged blood-spinal cord barrier and deliver therapeutic genes directly to injured spinal tissue in rats when administered intravenously within 6 hours of injury. The approach exploits the temporary disruption of the protective barrier that naturally occurs after spinal cord trauma, allowing non-invasive systemic delivery instead of requiring direct injection into the spinal cord. This finding could advance treatment of spinal cord injuries by enabling safer delivery of therapeutic proteins that promote healing and reduce secondary damage.
In a preclinical study published on bioRxiv, researchers investigated whether intravenously administered mRNA-lipid nanoparticles could exploit the temporary disruption of the blood-spinal cord barrier following acute injury to deliver therapeutic genes. Using a rat spinal cord injury model, they administered lipid nanoparticles loaded with reporter mRNA intravenously within 6 hours post-injury and tracked transgene expression across tissues. The nanoparticles successfully crossed the damaged barrier and achieved local gene expression in the injured spinal cord within 3 hours, with expression persisting for up to 5 days. The transgenes were expressed in multiple cell types including astrocytes, oligodendrocytes, microglia, and neurons. This approach addresses a major clinical limitation of protein-based therapies—their short half-lives and the invasiveness of direct intraspinal administration—by enabling systemic delivery of mRNA that produces therapeutic proteins locally at the injury site.
What's missing
The study was conducted only in rats, and the timeline for potential human clinical trials is not discussed. Additionally, the long-term safety profile of lipid nanoparticles and potential off-target effects in peripheral organs receiving transgene expression are not fully addressed in the available abstract.
How coverage differed
This is a preprint from bioRxiv presenting preliminary research findings. The source maintains a neutral, technical tone focused on methodology and results. No sources presented alternative interpretations or critical perspectives, as this appears to be the only coverage of this specific preprint study.
What different sources said
- bioRxivCenter
Intravenously Delivered Lipid Nanoparticles Access Acute Spinal Cord Injury via Disrupted Vasculature
Related
Widespread US Heat Wave Brings Dangerous Temperatures Across Multiple Regions
A significant heat wave is spreading across the central United States with heat index values forecast to exceed 110 degrees in parts of Texas and 100 degrees across multiple states including Missouri, Kansas, Iowa, Arkansas, and Tennessee. The National Weather Service warns that early-season heat waves pose greater risks for heat-related illness and could break daily temperature records across numerous states. The extreme heat is expected to impact more than 20 cities, with temperatures 10-20 degrees above normal in some regions, particularly the Upper Midwest and Great Lakes area.
Study Finds Noncognitive Skills Like Motivation and Curiosity Critical to Academic Success
Researchers at Queen Mary University of London conducted a major study showing that noncognitive skills such as motivation, curiosity, academic interest, and self-belief significantly influence how children translate their genetic potential into actual academic achievement. The research highlights that beyond innate ability, psychological and behavioral factors are essential determinants of educational outcomes. This finding suggests that interventions targeting motivation and attitude may be as important as traditional academic support in improving student performance.
NASA Announces Four-Person Crew for Artemis III Moon Mission
NASA has announced the crew for Artemis III, consisting of NASA astronauts Andre Douglas, Randy Bresnik, and Frank Rubio, along with ESA astronaut Luca Parmitano. The mission will test integrated operations between NASA's Orion spacecraft and commercial lunar landers from SpaceX and Blue Origin. This represents a significant step in NASA's plan to return humans to the Moon and establish sustainable lunar exploration capabilities.